Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Tastermonial (platform abbreviation: PSL) is a SaaS platform focused on metabolic health, positioned as an “evidence layer for metabolic ingredients.” Through structured self-experiments combined with real biomarker data such as CGM (continuous glucose monitor) readings, it helps users verify how diet, supplements, or medications (such as GLP-1) affect their own metabolism, then generates shareable evidence profiles.
Core functional modules: The platform’s core is its “experiment protocol.” Users pose a question, such as what causes glucose spikes or whether a supplement works, wear a CGM, and log their meals. After comparing a baseline period with an intervention period, they receive a clear conclusion: effective, ineffective, or inconclusive. The platform also provides shareable data cards, video testimonials, and public “evidence profiles,” giving it strong social and marketing attributes.
Data security and compliance: The platform’s terms clearly state that “users own their data,” with support for exporting and deleting data at any time. In brand-sponsored experiments, only experiment data is shared without revealing identity unless the user authorizes it. The platform also strictly prohibits users from offering medical advice or falsifying data through the platform.
Third-party integrations and deployment: The platform relies heavily on data input from CGM hardware and is cloud-based. The available text does not mention other software APIs or developer support.
Team collaboration and permissions: The product is designed for individual consumer users and does not include traditional enterprise software team-collaboration features. However, it does provide B2B brand partners with a channel to access user experiment data.
Pricing is charged per experiment. A 3-day free experiment is available, but users need to bring their own CGM. Paid experiments vary by duration and included hardware or supplements, ranging from $35 for a 7-day berberine challenge to $249 for a 14-day GLP-1 + protein muscle-preservation experiment.
The strengths are its rigorous experiment logic, clear and unambiguous conclusions, and explicit user data ownership. It also turns dry health data into shareable marketing assets, creating a closed loop between consumers and brands. The downsides are its heavy dependence on CGM hardware, which creates a relatively high barrier to entry, and the platform’s explicit statement that it does not provide medical diagnosis, limiting its usefulness as health guidance.
Best suited for biohacker-style users focused on their own metabolic health, patients using medications such as GLP-1, and supplement brands that need real user data as evidence.
The source text does not provide information about network restrictions, so access from China is unknown. Because the platform involves health data and USD payments, users in mainland China may face payment barriers and difficulty obtaining CGM hardware. Comparable alternatives include metabolic tracking apps such as Levels and Nutrisense.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on 1nme.com official site.
1nme.com is an United States Health provider. TG4G tracks its product information, with monthly pricing from $35.00, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach 1nme.com directly.